Novel human EGF-family proteins and polynucleotides encoding the same

Details for Australian Patent Application No. 2002306696 (hide)

Owner Lexicon Pharmaceuticals, Inc.

Inventors Yu, Xuanchuan; Miranda, Maricar

Agent Pizzeys

Pub. Number AU-B-2002306696

PCT Number PCT/US02/07477

PCT Pub. Number WO2002/072611

Priority 60/275,013 12.03.01 US

Filing date 6 March 2002

Wipo publication date 24 September 2002

Acceptance publication date 20 December 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C07K 14/485 (2006.01) Peptides having more than 20 amino acids

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/275,013 12.03.01 US

20 March 2003 Application Open to Public Inspection

  Published as AU-B-2002306696

26 July 2007 Change of Name(s) of Applicant(s), Section 104

  Lexicon Genetics Incorporated The name of the applicant has been changed to Lexicon Pharmaceuticals, Inc.

20 December 2007 Application Accepted

  Published as AU-B-2002306696

17 April 2008 Standard Patent Sealed

29 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002306697-Digital options having demand-based, adjustable returns, and trading exchange therefor

2002306695-STRUCTURED ORGANIC MATERIALS AND DEVICES USING LOWENERGY PARTICLE BEAMS